Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatitis C | 4 | 2024 | 174 | 1.190 |
Why?
|
| Drug Users | 3 | 2022 | 24 | 1.140 |
Why?
|
| Colorectal Neoplasms | 5 | 2024 | 980 | 0.980 |
Why?
|
| Adenoma | 2 | 2024 | 250 | 0.730 |
Why?
|
| Computer Simulation | 4 | 2024 | 1102 | 0.690 |
Why?
|
| Early Detection of Cancer | 5 | 2024 | 422 | 0.660 |
Why?
|
| Colonoscopy | 4 | 2024 | 281 | 0.600 |
Why?
|
| HIV Infections | 6 | 2022 | 848 | 0.520 |
Why?
|
| Models, Theoretical | 4 | 2024 | 493 | 0.470 |
Why?
|
| Cost-Benefit Analysis | 3 | 2024 | 466 | 0.430 |
Why?
|
| Hepacivirus | 3 | 2024 | 131 | 0.420 |
Why?
|
| Opioid-Related Disorders | 2 | 2024 | 193 | 0.380 |
Why?
|
| Pre-Exposure Prophylaxis | 3 | 2021 | 148 | 0.320 |
Why?
|
| Chicago | 6 | 2022 | 1431 | 0.310 |
Why?
|
| Occult Blood | 2 | 2024 | 18 | 0.300 |
Why?
|
| Referral and Consultation | 2 | 2021 | 345 | 0.290 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2024 | 144 | 0.280 |
Why?
|
| Neoplasms | 2 | 2018 | 3065 | 0.270 |
Why?
|
| Population Growth | 1 | 2005 | 12 | 0.260 |
Why?
|
| Fractals | 1 | 2005 | 42 | 0.260 |
Why?
|
| Emigration and Immigration | 1 | 2005 | 48 | 0.250 |
Why?
|
| Substance Abuse, Intravenous | 2 | 2024 | 59 | 0.250 |
Why?
|
| Bayes Theorem | 2 | 2024 | 381 | 0.250 |
Why?
|
| Incidence | 4 | 2022 | 1601 | 0.240 |
Why?
|
| Naloxone | 1 | 2024 | 68 | 0.240 |
Why?
|
| Reproduction | 1 | 2005 | 199 | 0.230 |
Why?
|
| Methadone | 1 | 2024 | 46 | 0.230 |
Why?
|
| Opiate Substitution Treatment | 1 | 2024 | 41 | 0.230 |
Why?
|
| Humans | 26 | 2024 | 89924 | 0.230 |
Why?
|
| Risk-Taking | 2 | 2022 | 155 | 0.220 |
Why?
|
| Homosexuality, Male | 3 | 2022 | 304 | 0.220 |
Why?
|
| Narcotic Antagonists | 1 | 2024 | 161 | 0.210 |
Why?
|
| Hepatitis B | 1 | 2023 | 76 | 0.210 |
Why?
|
| Policy | 1 | 2022 | 35 | 0.200 |
Why?
|
| Virus Replication | 1 | 2023 | 326 | 0.200 |
Why?
|
| Health Information Exchange | 1 | 2021 | 12 | 0.200 |
Why?
|
| Sexual and Gender Minorities | 2 | 2022 | 213 | 0.190 |
Why?
|
| Hand Disinfection | 1 | 2021 | 17 | 0.190 |
Why?
|
| Systems Analysis | 1 | 2021 | 17 | 0.190 |
Why?
|
| Viremia | 1 | 2021 | 49 | 0.190 |
Why?
|
| Workflow | 2 | 2018 | 81 | 0.190 |
Why?
|
| Community Networks | 1 | 2021 | 30 | 0.190 |
Why?
|
| Masks | 1 | 2021 | 29 | 0.190 |
Why?
|
| Social Class | 1 | 2022 | 137 | 0.190 |
Why?
|
| Hepatitis C, Chronic | 1 | 2022 | 91 | 0.190 |
Why?
|
| Young Adult | 6 | 2022 | 6408 | 0.180 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 436 | 0.180 |
Why?
|
| Crime | 1 | 2020 | 37 | 0.180 |
Why?
|
| Adolescent | 6 | 2022 | 9339 | 0.170 |
Why?
|
| Criminals | 1 | 2020 | 33 | 0.170 |
Why?
|
| Viral Hepatitis Vaccines | 1 | 2019 | 5 | 0.170 |
Why?
|
| Disease Transmission, Infectious | 1 | 2019 | 58 | 0.160 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 159 | 0.160 |
Why?
|
| Residence Characteristics | 1 | 2020 | 203 | 0.160 |
Why?
|
| Transgender Persons | 1 | 2020 | 109 | 0.150 |
Why?
|
| Models, Biological | 1 | 2005 | 1765 | 0.150 |
Why?
|
| Adult | 9 | 2024 | 26810 | 0.150 |
Why?
|
| Algorithms | 2 | 2024 | 1908 | 0.150 |
Why?
|
| Patient Compliance | 1 | 2019 | 230 | 0.150 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 2393 | 0.140 |
Why?
|
| Male | 11 | 2024 | 42657 | 0.140 |
Why?
|
| Smoking Cessation | 1 | 2019 | 258 | 0.140 |
Why?
|
| Illinois | 3 | 2024 | 485 | 0.130 |
Why?
|
| Machine Learning | 1 | 2018 | 270 | 0.130 |
Why?
|
| Mass Screening | 3 | 2024 | 646 | 0.120 |
Why?
|
| Calibration | 2 | 2024 | 103 | 0.110 |
Why?
|
| Middle Aged | 5 | 2024 | 26132 | 0.100 |
Why?
|
| Female | 7 | 2024 | 46571 | 0.100 |
Why?
|
| Aged | 5 | 2024 | 19240 | 0.080 |
Why?
|
| United States | 3 | 2024 | 7102 | 0.070 |
Why?
|
| Pandemics | 2 | 2023 | 778 | 0.070 |
Why?
|
| Hematologic Tests | 1 | 2024 | 15 | 0.060 |
Why?
|
| Needle Sharing | 1 | 2024 | 15 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2021 | 2887 | 0.060 |
Why?
|
| Monte Carlo Method | 1 | 2024 | 186 | 0.060 |
Why?
|
| Drug Overdose | 1 | 2024 | 78 | 0.060 |
Why?
|
| Hepatitis B virus | 1 | 2023 | 45 | 0.050 |
Why?
|
| Virion | 1 | 2023 | 59 | 0.050 |
Why?
|
| Pan troglodytes | 1 | 2024 | 203 | 0.050 |
Why?
|
| HIV | 1 | 2022 | 48 | 0.050 |
Why?
|
| Texas | 1 | 2022 | 116 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2023 | 263 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 2653 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 6780 | 0.050 |
Why?
|
| Infectious Disease Medicine | 1 | 2021 | 7 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 50 | 0.050 |
Why?
|
| California | 1 | 2021 | 146 | 0.050 |
Why?
|
| Uncertainty | 1 | 2021 | 76 | 0.050 |
Why?
|
| San Francisco | 1 | 2020 | 24 | 0.050 |
Why?
|
| Geography | 1 | 2021 | 227 | 0.050 |
Why?
|
| Computational Biology | 1 | 2024 | 551 | 0.050 |
Why?
|
| Sexual Partners | 1 | 2021 | 101 | 0.050 |
Why?
|
| Animals | 3 | 2024 | 27526 | 0.050 |
Why?
|
| Probability | 1 | 2021 | 350 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2021 | 371 | 0.050 |
Why?
|
| Kinetics | 1 | 2023 | 1534 | 0.050 |
Why?
|
| Public Health | 1 | 2021 | 140 | 0.040 |
Why?
|
| Health Behavior | 1 | 2021 | 185 | 0.040 |
Why?
|
| Poverty | 1 | 2021 | 183 | 0.040 |
Why?
|
| Mice | 2 | 2024 | 11851 | 0.040 |
Why?
|
| Age Factors | 1 | 2024 | 1880 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2024 | 2018 | 0.040 |
Why?
|
| Liver | 1 | 2024 | 1211 | 0.040 |
Why?
|
| Health Policy | 1 | 2021 | 188 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 451 | 0.040 |
Why?
|
| Vaccine Potency | 1 | 2019 | 1 | 0.040 |
Why?
|
| Forecasting | 1 | 2020 | 304 | 0.040 |
Why?
|
| Internet | 1 | 2021 | 323 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 983 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2022 | 482 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 262 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 595 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 1075 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2019 | 236 | 0.040 |
Why?
|
| Vaccination | 1 | 2019 | 279 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 1214 | 0.030 |
Why?
|
| Hospitalization | 1 | 2022 | 888 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 1544 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1729 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2019 | 576 | 0.030 |
Why?
|
| Decision Making | 1 | 2021 | 670 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2019 | 351 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1250 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 8270 | 0.020 |
Why?
|